Alkeus Pharmaceuticals Presents Positive Interim Data Showing Gildeuretinol Halted Stargardt Disease Progression
All three patients treated for two years or more have remained free of symptoms and disease progression while taking gildeuretinol. • TEASE-3 is the first clinical trial in early-stage Stargardt disease, a leading cause of inherited blindness in children and young adults. • Data to be presented…#goldengate #towerbuilding #cambridge #mass #leonidesaad #phd #tease1 #alkeus #michaelbgorin #ucla (Source: Reuters: Health)
Source: Reuters: Health - January 10, 2024 Category: Consumer Health News Source Type: news

Experts warn against risky procedure that changes people's eye color - but could leave you blind
If a person isn't happy with their eye color and wishes to permanently change it, there are three possible options, but they are invasive, expensive and can lead to total blindness. (Source: the Mail online | Health)
Source: the Mail online | Health - January 4, 2024 Category: Consumer Health News Source Type: news

Prevent Blindness Issues Call for Nominations for the 2024 Jenny Pomeroy Award for Excellence in Vision and Public Health, and Rising Visionary Award
Prevent Blindness to present national awards at the 13th Annual Prevent Blindness Focus on Eye Health Summit, July 10-11, 2024 CHICAGO, Jan. 4, 2024 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading eye health and safety organization, is issuing the call for nominations for... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 4, 2024 Category: Pharmaceuticals Tags: AWD NPT TDS Source Type: news

Flash blindness recovery for pilots in the modern cockpit - Arizpe JM, McAnally RE, Hart MV, Kuyk TK, Smith PA, Goettl BP.
Intense light can cause flash blindness, a temporary visual impairment. We investigated how various factors influenced time to recover from flash blindness for a task resembling reading a cockpit heading display. Prior studies used only reflective displays... (Source: SafetyLit)
Source: SafetyLit - January 1, 2024 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Illuminating The Options For Treating Night Blindness
Night blindness is a relatively rare genetic condition, with an estimated prevalence of 1 in 7,000 to 10,000 individuals in the US. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 1, 2024 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news

A potential case of change blindness in an officer-involved shooting - Martin JA, Suss J.
The perceptual phenomenon of change blindness has been widely researched in the scientific literature, mostly in laboratory studies. This case study reviews the fatal shooting of a woman who suddenly backed her car in the general direction of law enforceme... (Source: SafetyLit)
Source: SafetyLit - January 1, 2024 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Prevent Blindness Joins National Glaucoma Awareness Month in January to Educate the Public and Professionals on the "Silent Thief of Sight"
Prevent Blindness provides free glaucoma educational resources, including a new promotional toolkit for "The Glaucoma Community," glaucoma patient testimonial, and medical expert interview videos CHICAGO, Dec. 27, 2023 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading eye... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 27, 2023 Category: Pharmaceuticals Tags: NPT CSR Source Type: news

Watch out for cork accidents this festive season
Cork eye injuries are an often overlooked and a substantial threat to optical health, that could even lead to permanent blindness. (Source: Daily Express - Health)
Source: Daily Express - Health - December 20, 2023 Category: Consumer Health News Source Type: news

Electrifying Results: Restoring Partial Color Vision In Retinitis Pigmentosa Patients With Retinal Implants
Retinal implants have recently gained attention as a potential treatment for RP-induced color blindness. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 16, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news

A Golden Opportunity: Using Gold Contacts To Correct Color Blindness
Modern technology offers a solution in the form of color-correcting contact lenses, with gold contacts being a promising new development that offers hope. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 12, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news

Printing A Rainbow: The Technological Advances In Correcting Color Vision
Color blindness is a common genetic disorder affecting a large population segment. Despite its prevalence, there is still a lack of effective treatments for this condition. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 10, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news

Seeing The World Through Color-Blind Eyes
While there is no cure for color blindness, several devices and products can assist individuals in experiencing more enhanced and nuanced color vision. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 8, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news

Durham biotech seeks partner to advance its gene therapy
Atsena Therapeutics is looking for a partner to advance one of its gene therapy programs targeting blindness. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 4, 2023 Category: Biotechnology Authors: Zac Ezzone Source Type: news

Prevent Blindness Declares Third Annual Geographic Atrophy Awareness Week as Dec. 4-10, 2023
Prevent Blindness provides free geographic atrophy educational resources for patients, care partners and healthcare professionals, including new Focus on Eye Health Expert series episode, Web resource, Fact Sheets and More CHICAGO, Nov. 30, 2023 /PRNewswire/ -- Prevent Blindness, the... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 30, 2023 Category: Pharmaceuticals Tags: NPT Source Type: news

How Late Can You Give Routine Newborn Care?
Discussion Routine newborn screening and treatment is focused on assisting the infant’s transition to extrauterine life, screening for health problems that may or may not be easily identifiable, and preventing acute or chronic health problems. Healthy infants begin with healthy pregnancies including risk factor assessment and screening of mothers. Such routine maternal screening and treatment does or may include glucose tolerance tests, ultrasound examinations, screenings for maternal blood type (with appropriate administration of Rho(D) immunoglobulin if appropriate), Hepatitis B, Neisseria gonorrhea, Chlamydia, Cyt...
Source: PediatricEducation.org - November 20, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news